NFKB1 and Cognitive impairment: Developing drugs to modulate the production of TNFα, such as NF-κB, P38 MAPK, and TNF receptor antagonist inhibitors, may be potential candidates for the treatment of cognitive impairment, AD, and other neurodegenerative diseases.